National Vision
EYE Nasdaq Specialty Stores Financials FY2016βFY2025
National Vision's revenue rose 9.0% to $2.0 billion in fiscal 2025. Its operating margin was 3.0%, up from β0.6% a year earlier. Free cash flow was $73 million, up 92.6%. It paid out $3 million in dividends and buybacks, 4% of free cash flow. The diluted share count rose 2.5%.
What National Vision does
No business description yet.
- Legal name
- National Vision Holdings, Inc.
- Fiscal year ends
- January 3, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-014379
0001710155
Revenue and margins
National Vision had $2.0B of revenue in fiscal 2025, up 9.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 5.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $73.5M in fiscal 2025, 3.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
National Vision returned $3.2M to shareholders in fiscal 2025, 4% of free cash flow. The diluted share count rose 2.5%.
Value National Vision yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$207M and divides by 80.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 30.6x Β· peers 10.1x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably National Vision can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $306M | $229M | $150M | $73.9M | $38.7M |
| Debt incl. finance leases | $570M | $568M | $461M | $350M | $246M |
| Net debt / EBITDA | 1.0x | 2.4x | 2.7x | 3.4x | 1.4x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.4x | 0.3x |
| Interest coverage | 6.8x | 3.1x | 2.1x | β0.8x | 3.1x |
| Current ratio | 1.5x | 1.4x | 1.0x | 0.5x | 0.6x |
| Quick ratio | 1.1x | 1.0x | 0.7x | 0.3x | 0.3x |
| Total assets | $2.3B | $2.3B | $2.2B | $2.0B | $2.0B |
| Total liabilities | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B |
| Shareholders' equity | $926M | $901M | $829M | $816M | $870M |
| Net debt (β = net cash) | $264M | $338M | $311M | $276M | $207M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.8M
1 insider
Sold, 12 months
$1.3M
2 insiders
Of sales under plans
100%
$1.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Michael J NicholsonDirector | Bought | 50,000 | $15.52 | $0.8M | Form 4 |
| Mar 11, 2026 | Alexander WilkesChief Executive Officer, Director | Sold plan | 35,000 | $26.54 | $0.9M | Form 4 |
| Mar 6, 2026 | Fahs L ReadeExecutive Chairman, Director | Sold plan | 11,672 | $29.58 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 8 | 6 / 8 | 7 / 8 |
| Accruals ratio | β10.7% | β7.8% | β5.9% |
| Altman Z'' | 1.10 | 0.34 | 0.82 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| National Vision EYE | $1.5B | 9.0% | 3.0% | 3.7% | 3.9% | 30.6x | 7 | |
| MarineMax HZO | $1.2B | β5.0% | 1.5% | 0.5% | 1.4% | β | 5 | Compare β |
| Sally Beauty SBH | $1.7B | β0.4% | 8.9% | 4.7% | 16.1% | 9.1x | 8 | Compare β |
| Five Below FIVE | $12.4B | 22.9% | 9.6% | 8.6% | 26.9% | 20.0x | 7 | Compare β |
| Academy Sports + Outdoors ASO | $3.8B | 2.0% | 8.5% | 3.7% | 17.6% | 10.1x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.2B | $1.4B | $1.5B | $1.7B | $1.7B | $2.1B | $1.6B | $1.8B | $1.8B | $2.0B |
| Gross profit | $651M | $738M | $823M | β | β | β | β | β | β | β |
| Operating income | $64.1M | $64.3M | $42.4M | $73.6M | $87.0M | $175M | $52.8M | $24.5M | β$10.4M | $58.8M |
| Interest expense | $39.1M | $55.5M | $37.3M | $33.3M | $48.3M | $25.6M | $16.9M | $11.7M | $13.4M | $19.1M |
| Pretax income | $25.0M | $4.2M | $4.9M | $30.5M | $38.7M | $149M | $52.3M | $9.6M | β$25.7M | $41.7M |
| Income tax | $11.6M | β$38.9M | β$18.8M | β$2.3M | $2.4M | $21.1M | $15.5M | $6.0M | $1.5M | $12.1M |
| Net income | $13.3M | $43.1M | $23.7M | $32.8M | $36.3M | $128M | $42.1M | β$65.9M | β$28.5M | $29.6M |
| Diluted EPS | $0.23 | $0.70 | $0.30 | $0.40 | $0.44 | $1.43 | $0.52 | β$0.84 | β$0.36 | $0.37 |
| Diluted shares | 0.06B | 0.06B | 0.08B | 0.08B | 0.08B | 0.10B | 0.08B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $97.6M | $90.3M | $107M | $165M | $235M | $259M | $119M | $173M | $134M | $146M |
| Capital expenditure | $90.0M | $93.2M | $105M | $101M | $76.8M | $95.5M | $114M | $115M | $95.5M | $72.8M |
| Free cash flow | $7.6M | β$3.0M | $2.1M | $63.8M | $158M | $163M | $5.7M | $58.3M | $38.1M | $73.5M |
| Depreciation and amortization | $52.7M | $62.0M | $74.3M | $87.2M | $91.6M | $97.1M | $88.7M | $89.9M | $91.3M | $91.2M |
| Stock-based compensation | $4.3M | $5.2M | $20.9M | $12.7M | $10.7M | $14.9M | $13.5M | $20.2M | $16.7M | $23.7M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.2M | $0.0M | $1.9M | $25.6M | $0.7M | $73.3M | $84.4M | $28.4M | $3.1M | $3.2M |
| Dividends paid | $0.0M | $171M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.2M | $171M | $1.9M | $25.7M | $0.7M | $73.3M | $84.4M | $28.4M | $3.1M | $3.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.9M | $4.2M | $17.1M | $39.3M | $374M | $306M | $229M | $150M | $73.9M | $38.7M |
| Total debt | $746M | $569M | $578M | $536M | $625M | $544M | $546M | $445M | $337M | $237M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $33.3M | $30.8M | $26.5M | $21.3M | $16.1M | $12.8M | $9.4M |
| Current assets | $147M | $163M | $215M | $235M | $567M | $515M | $474M | $397M | $250M | $226M |
| Current liabilities | $200M | $211M | $212M | $273M | $329M | $344M | $344M | $398M | $468M | $412M |
| Inventory | $87.1M | $91.2M | $116M | $128M | $111M | $124M | $123M | $120M | $93.9M | $89.3M |
| Property and equipment, net | $256M | $302M | $355M | $367M | $341M | $346M | $360M | $360M | $362M | $345M |
| Total assets | $1.5B | $1.6B | $1.7B | $2.0B | $2.3B | $2.3B | $2.3B | $2.2B | $2.0B | $2.0B |
| Total liabilities | $1.1B | $927M | $918M | $1.3B | $1.4B | $1.4B | $1.4B | $1.3B | $1.2B | $1.1B |
| Shareholders' equity | $400M | $655M | $743M | $776M | $907M | $926M | $901M | $829M | $816M | $870M |
| Margins | ||||||||||
| Gross margin | 54.5% | 53.7% | 53.6% | β | β | β | β | β | β | β |
| Operating margin | 5.4% | 4.7% | 2.8% | 4.3% | 5.1% | 8.4% | 3.2% | 1.4% | β0.6% | 3.0% |
| EBITDA margin | 9.8% | 9.2% | 7.6% | 9.3% | 10.4% | 13.1% | 8.6% | 6.5% | 4.4% | 7.6% |
| Net margin | 1.1% | 3.1% | 1.5% | 1.9% | 2.1% | 6.2% | 2.6% | β3.8% | β1.6% | 1.5% |
| FCF margin | 0.6% | β0.2% | 0.1% | 3.7% | 9.2% | 7.9% | 0.3% | 3.3% | 2.1% | 3.7% |
| Returns | ||||||||||
| Return on capital | β | 5.5% | 3.4% | 5.6% | 6.5% | 12.6% | 3.1% | 1.0% | β0.7% | 3.9% |
| Return on capital employed | β | 4.8% | 3.0% | 4.6% | 4.6% | 8.9% | 2.7% | 1.3% | β0.6% | 3.8% |
| Return on equity | β | 8.2% | 3.4% | 4.3% | 4.3% | 14.0% | 4.6% | β7.6% | β3.5% | 3.5% |
| Return on assets | β | 2.8% | 1.5% | 1.8% | 1.7% | 5.5% | 1.8% | β3.0% | β1.4% | 1.5% |
| Growth | ||||||||||
| Revenue growth | 12.6% | 15.0% | 11.8% | 12.2% | β0.7% | 21.5% | β20.9% | 6.8% | 3.8% | 9.0% |
| Net income growth | 268.9% | 223.3% | β45.2% | 38.7% | 10.6% | 253.5% | β67.2% | β256.5% | β | β |
| EPS growth | 283.3% | 204.4% | β57.1% | 33.3% | 10.0% | 225.0% | β63.6% | β261.5% | β | β |
| FCF growth | 26.6% | β139.2% | β | 2,886.2% | 148.1% | 3.3% | β96.5% | 931.0% | β34.5% | 92.6% |
| Share count change | 1.9% | 8.8% | 27.4% | 3.3% | 1.4% | 16.1% | β16.5% | β2.1% | β0.0% | 2.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 6.3x | 4.5x | 4.8x | 3.3x | 1.6x | 1.0x | 2.4x | 2.7x | 3.4x | 1.4x |
| Debt / equity | 1.9x | 0.9x | 0.8x | 0.7x | 0.7x | 0.6x | 0.6x | 0.6x | 0.4x | 0.3x |
| Interest coverage | 1.6x | 1.2x | 1.1x | 2.2x | 1.8x | 6.8x | 3.1x | 2.1x | β0.8x | 3.1x |
| Current ratio | 0.7x | 0.8x | 1.0x | 0.9x | 1.7x | 1.5x | 1.4x | 1.0x | 0.5x | 0.6x |
| Quick ratio | 0.3x | 0.3x | 0.5x | 0.4x | 1.4x | 1.1x | 1.0x | 0.7x | 0.3x | 0.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.5% | 6.8% | 6.8% | 5.9% | 4.5% | 4.6% | 6.9% | 6.5% | 5.2% | 3.7% |
| Stock comp / revenue | 0.4% | 0.4% | 1.4% | 0.7% | 0.6% | 0.7% | 0.8% | 1.2% | 0.9% | 1.2% |
| Payouts / FCF | 2.5% | β | 90.3% | 40.2% | 0.4% | 44.9% | 1,493.3% | 48.8% | 8.1% | 4.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 6.0 | 6.0 | 5.0 | 6.0 | 4.0 | 5.0 | 6.0 | 7.0 |
| Altman Z'' | 0.4 | 0.9 | 1.2 | 0.9 | 1.8 | 2.1 | 1.7 | 1.1 | 0.3 | 0.8 |
| Accruals ratio | β | β3.0% | β5.1% | β7.2% | β9.1% | β5.7% | β3.4% | β10.7% | β7.8% | β5.9% |
Source: SEC EDGAR XBRL filings (CIK 0001710155). Data updated October 19, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.